Skip to main content


Figure 3 | Critical Care

Figure 3

From: Regional citrate anticoagulation in cardiac surgery patients at high risk of bleeding: a continuous veno-venous hemofiltration protocol with a low concentration citrate solution

Figure 3

Platelet count and antithrombin III throughout days of RCA-CVVH (comparison versus day 1, ** P < 0.02; *** P < 0.005). Data are expressed as median, interquartile range (q1 to q3), minimum (min), maximum (max). On the bottom, transfusion rate (units/day) during RCA-CVVH days and comparison of transfusion rates among different anticoagulation modalities. RCA-CVVH, regional citrate anticoagulation-continuous veno-venous hemofiltration.

Back to article page